Propensity Score Matching Analysis For Osimertinib Versus Comparator First-Generation Egfr Tyrosine Kinase Inhibitors As First-Line Treatment In Patients With Advanced Egfr-Mutated Non-Small Cell Lung Cancer:A Chinese, Multicenter, Real-World Cohort Study.
Osimertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Propensity Score Matching Analysis For Osimertinib Versus Comparator First-Generation Egfr Tyrosine Kinase Inhibitors As First-Line Treatment In Patients With Advanced Egfr-Mutated Non-Small Cell Lung Cancer:A Chinese, Multicenter, Real-World Cohort Study. ### Output: Osimertinib